Clinical Trial Update: Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury [NA]

View source ↗

Summary

A randomized clinical trial is ongoing to evaluate neutrophil and monocyte deactivation using the SeLective Cytopheretic Device for acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SeLective Cytopheretic Device

Snippet

Sponsor: SeaStar Medical | Conditions: Acute Kidney Injury | NA | Status: RECRUITING